Sotevtamab, a novel bispecific antibody , is sparking considerable interest within the oncology community, particularly regarding the promise for managing hematologic cancers. This therapy functions by simultaneously targeting CD3 and the tumor-associated antigen, like CD19, for triggering the immune response to can destroy cancer populations. P… Read More

Ibritumomab, sometimes referred to as Zevalin, represents the novel form of specific radiotherapy used to treat certain kinds of non-Hodgkin's lymphoma , particularly recurring follicular lymphoma . This is a monoclonal molecule linked to Y-90 , the emitting substance that provides precise radiation directly within malignant cells. Different fro… Read More